Aurora Cannabis Inc.

ACB Healthcare Drug Manufacturers Specialty & Generic

Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025. In the quarter to June 2026, revenue fell 31.2%, EPS grew 75.0%, free cash flow fell 293.6% and total debt fell 82.5%, each against the same quarter a year earlier.

3.99 0.11 −2.68%
Market cap
$265.8M
P/E
0.0×
Fwd P/E
−783×
Dividend yield
—
F-score
4/9
Altman Z
−12.34
Beneish M
−2.53
Dividend safety
n/a
Jun '17 Jun '18 Jun '19 Jun '20 Jun '21 Jun '22 Jun '23 Mar '24 Mar '25 Mar '26
Piotroski F-Score
— — 3 4 5 4 4 — — 4
P/E ratio
0.00 1,381.62 0.00 0.00 0.00 0.00 0.00 0.00 39.91 0.00
Altman Z-Score
3.90 6.87 5.50 (0.75) (0.26) (7.12) (7.40) (9.41) (8.69) (12.34)
P/S ratio
330.36 741.08 424.53 57.79 79.86 16.22 0.98 0.93 0.98 0.80
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
5.15 5.00 3.86 (1.65) (0.98) (14.31) (22.93) (20.09) (18.86) (25.83)
Beneish M-Score
— 1.88 0.94 — — (11.28) — — (2.59) (2.53)
P/Operating CF
(566.83) (500.87) (547.52) (47.69) (93.01) (32.69) (22.63) (11.65) 89.10 (733.60)
P/B ratio
27.20 26.17 23.98 7.58 9.61 5.42 0.50 0.42 0.55 0.50
Price to Tangible BV
40.58 70.79 198.93 20.51 25.03 6.07 0.59 0.49 0.64 0.56
EV/Sales
324.21 742.05 425.67 59.08 79.65 15.20 0.71 0.62 0.72 0.53
EV/EBITDA
305.78 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.93 0.00
EV/Operating CF
0.00 (378.12) (278.37) (26.31) (44.07) (17.43) (0.83) (2.45) 15.51 (12.65)
EV/FCF
0.00 (90.74) (101.55) (12.71) (38.03) (16.48) (0.82) (2.30) (302.77) (4.89)
Quick Ratio
7.54 2.19 1.09 0.82 4.31 3.70 1.41 1.83 2.06 3.13
Current Ratio
8.25 2.92 1.52 1.54 5.72 5.13 1.98 3.42 4.31 5.94
Net Debt/EBITDA
10.97 (0.57) (1.25) (0.96) 0.28 1.65 0.35 8.70 (2.77) 5.11
Debt/Assets
19.78% 10.64% 11.72% 19.08% 15.10% 24.29% 24.62% 11.92% 11.63% 3.02%
Debt/Equity
0.29 0.13 0.15 0.25 0.19 0.40 0.47 0.17 0.16 0.04
Asset Turnover
0.09 0.05 0.07 0.07 0.09 0.12 0.23 0.30 0.40 0.44
Operating CF/Net income
0.81 (1.14) 0.66 0.10 0.30 0.06 0.44 1.04 7.06 0.11
Capex/Depreciation
(29.87) (22.49) (4.69) (3.06) (0.34) (0.13) 0.00 (0.13) (0.64) (1.19)
Interest Coverage
(1.70) (8.05) (7.66) (6.33) (4.26) (3.22) (26.77) (3.27) 0.59 (25.79)
ROE
(11.52%) 8.12% (9.66%) (100.72%) (34.17%) (128.39%) (44.89%) (11.98%) 0.37% (21.82%)
ROA
(6.53%) 6.48% (7.76%) (79.21%) (26.41%) (93.92%) (25.69%) (7.38%) 0.26% (16.82%)
ROIC
(6.47%) (4.09%) (4.20%) (12.33%) (8.90%) (33.21%) 0.00% (5.60%) 0.59% (7.98%)
Return on Tangible Assets
(6.01%) 18.40% (29.28%) (302.50%) (60.15%) (206.11%) (47.30%) (11.00%) 0.36% (26.81%)
Average Days of Receivables
46.71 99.83 165.36 70.81 84.06 77.59 64.15 61.33 45.16 50.75
Research and Development Expense of Revenue
1.74% 3.04% 5.96% 9.35% 4.67% 4.69% 2.81% 1.32% 1.07% 1.25%
Selling, General and Administrative Expense of Revenue
136.53% 199.04% 152.74% 127.80% 79.46% 85.39% 78.61% 58.04% 48.49% 54.12%
Intangible Assets out of Total Assets
0.22 0.52 0.70 0.48 0.48 0.07 0.08 0.10 0.10 0.10
Share Based Compensation of Revenue
41.98% 67.85% 43.17% 21.48% 8.25% 6.22% 0.00% 4.71% 3.36% 2.27%
Graham Net Nets
0.02 0.00 0.00 (0.01) 0.01 0.09 0.30 0.76 0.70 1.20
Graham Number
0.00 20.99 0.00 0.00 0.00 0.00 0.00 0.00 4.44 0.00
Earnings Yield
(2.32%) 0.07% (2.68%) (102.96%) (30.48%) (324.47%) (44.86%) (32.48%) 2.51% (47.71%)
Free Cash Flow Yield
0.00% (1.10%) (0.99%) (8.04%) (2.62%) (5.68%) (87.52%) (29.12%) (0.24%) (13.64%)
Revenue per Share
5.86 11.35 22.13 21.49 11.32 8.14 0.54 4.64 4.50 4.09
Operating CF per Share
(3.41) (16.80) (17.16) (26.04) (9.72) (4.04) (0.27) (1.17) 0.21 (0.17)
Capex per Share
(10.53) (56.70) (36.98) (27.07) (1.56) (0.46) 0.00 (0.08) (0.22) (0.27)
Free Cash Flow per Share
(13.94) (73.49) (54.14) (53.11) (11.28) (4.50) (0.27) (1.26) (0.01) (0.45)
Cash per Share
56.64 30.72 32.32 13.04 20.52 18.02 0.70 3.14 2.44 2.10
Shareholders Equity per Share
71.00 321.48 391.88 163.87 94.05 24.35 1.13 10.32 7.98 6.53
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
71.00 321.48 391.88 163.87 94.05 24.35 1.13 10.32 7.98 6.53
Free Cash Flow
(32.39) (281.47) (458.12) (513.88) (190.79) (96.71) (87.08) (54.25) (0.59) (25.30)
Working Capital
128.25 113.85 172.06 110.30 428.95 473.98 178.95 223.86 264.10 239.23
Capital Expenditures
(24.47) (217.14) (312.92) (261.90) (26.42) (9.93) (9.12) (3.47) (12.09) (15.52)
Net Current Asset Value
67.74 (100.74) (338.84) (176.34) 77.17 255.30 53.38 140.70 168.36 223.07
EV/EBIT
324.21 0.00 0.00 0.00 0.00 0.00 0.00 0.00 50.17 0.00
Capex to Sales
1.80 4.99 1.67 1.26 0.14 0.06 0.00 0.02 0.05 0.07
Price to Operating Income
330.36 0.00 0.00 0.00 0.00 0.00 0.00 0.00 67.69 0.00
Other line items
Depreciation/Fixed assets
0.02 0.05 0.12 0.12 0.16 0.40 0.10 0.13 0.10 0.15
Cash ROIC
(9.40%) (18.65%) (11.24%) (24.38%) (8.50%) (8.65%) (11.41%) (8.27%) (0.09%) (5.03%)
Accounts Receivable Turnover
7.81 6.38 3.87 3.32 4.53 4.30 5.16 6.21 7.69 7.39
Accounts Payable Turnover
0.37 0.70 0.87 2.50 3.58 3.15 6.24 3.43 2.32 2.97
Inventory Turnover
0.25 0.72 0.84 1.92 1.85 1.45 2.16 0.88 0.72 0.89
Average Days of Payables
1,588.67 883.61 633.23 111.65 79.27 127.45 26.98 153.98 172.56 100.39
Days of Inventory on Hand
2,140.09 804.65 685.39 183.71 188.40 255.22 158.19 490.04 560.54 347.40
Average Receivables
1.74 6.82 48.37 62.59 42.22 40.63 34.00 32.25 32.09 31.39
Average Payables
4.07 21.99 76.43 93.37 58.25 50.22 35.87 29.98 48.16 44.76
Average Inventory
5.99 21.46 79.51 121.12 112.38 109.03 103.77 117.58 155.00 149.28
Average Assets
149.70 874.15 2,830.68 3,115.91 2,054.39 1,445.00 776.50 658.97 617.26 523.94
Average Common Equity
84.83 698.15 2,273.54 2,450.64 1,588.06 1,056.98 444.37 405.79 441.78 403.93

Fold the line items

Columns are period end dates